TEACH: A Randomized, double-blind, multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with early stage ErbB2 Over expressing Breast Cancer: A STUDY OF TYKERB EVALUATION AFTER CHEMOTHERAPY

Project Details

Short titleTEACH: A Randomized, double-blind, multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with early stage ErbB2 Over expressing Breast Cancer: A STUDY OF TYKERB EVALUATION AFTER CHEMOTHERAPY
StatusFinished
Effective start/end date1/01/0731/12/16

Funding

  • Queen Elizabeth Hospital Birmingham